Detalhe da pesquisa
1.
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
Eur J Cancer
; 43(5): 867-76, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17307353
2.
[Non-publication is common among phase 1, single-center, not prospectively registered, or early terminated clinical drug trials]. / Hoeveel klinische geneesmiddelenstudies worden uiteindelijk gepubliceerd?
Ned Tijdschr Geneeskd
; 161: D1498, 2017.
Artigo
em Holandês
| MEDLINE | ID: mdl-28659210
3.
Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.
J Clin Oncol
; 18(21 Suppl): 119S-24S, 2000 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11060339
4.
Survival in hereditary breast cancer associated with germline mutations of BRCA2.
J Clin Oncol
; 17(11): 3396-402, 1999 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-10550133
5.
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.
J Clin Oncol
; 19(4): 924-30, 2001 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11181654
6.
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.
J Med Genet
; 41(10): 731-5, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15466005
7.
Possible consequences of applying guidelines to healthy women with a family history of breast cancer.
Eur J Hum Genet
; 11(8): 633-6, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12891386
8.
Survival in interval breast cancer in the DOM screening programme.
Eur J Cancer
; 31A(11): 1830-5, 1995 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8541108
9.
Breast cancer after a negative screen: follow-up of women participating in the DOM Screening Programme.
Eur J Cancer
; 28A(4-5): 893-5, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-1524918
10.
Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST).
Eur J Cancer
; 35(4): 620-6, 1999 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10492637
11.
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.
Eur J Cancer
; 40(8): 1150-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15110878
12.
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC).
Fam Cancer
; 1(3-4): 163-8, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-14574173
13.
Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.
J Epidemiol Community Health
; 50(1): 68-71, 1996 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-8762357
14.
Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
Dis Markers
; 15(1-3): 34-6, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10595248
15.
[Mass screening for breast cancer in women younger than 50; a literature review of the probable effect on mortality]. / Bevolkingsonderzoek naar borstkanker bij vrouwen jonger dan 50 jaar; een literatuuroverzicht van het te verwachten effect op de sterfte.
Ned Tijdschr Geneeskd
; 135(38): 1766-7, 1991 Sep 21.
Artigo
em Holandês
| MEDLINE | ID: mdl-1922537
16.
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.
Breast Cancer Res Treat
; 102(3): 357-63, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17051427
17.
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
Br J Cancer
; 96(9): 1335-42, 2007 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17426707
18.
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Br J Surg
; 93(8): 961-8, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16758466
19.
Survival and prognostic factors in BRCA1-associated breast cancer.
Ann Oncol
; 17(3): 391-400, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322115
20.
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.
Int J Gynecol Cancer
; 16 Suppl 2: 552-5, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17010071